Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy

References

• RodeghieroFStasiRGernsheimerTStandardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood200911311 2386 239319005182
   PubMed Web of Science ®Google Scholar
• TerrellDRBeebeLAVeselySKNeasBRSegalJBGeorgeJNThe incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reportsAm J Hematol2010853 174 18020131303
   PubMed Web of Science ®Google Scholar
• NeunertCEBuchananGRImbachPIntercontinental Cooperative ITP Study Group Registry II ParticipantsBleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS)Blood201312122 4457 446223550040
   PubMed Web of Science ®Google Scholar
• Heitink-PolléKMNijstenJBoonackerCWde HaasMBruinMCClinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysisBlood201412422 3295 330725305206
   PubMed Web of Science ®Google Scholar
• JernåsMHouYStrömberg CélindFAltered cytokine levels in pediatric ITPPlatelets2015266 589 59225806433
   PubMed Web of Science ®Google Scholar
• JernåsMHouYStrömberg CélindFDifferences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITPBlood201312210 1789 179223869085
   PubMed Web of Science ®Google Scholar
• PsailaBPetrovicAPageLKMenellJSchonholzMBusselJBIntracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 casesBlood200911423 4777 478319767509
   PubMed Web of Science ®Google Scholar
• NeunertCLimWCrowtherMCohenASolbergLJrCrowtherMAAmerican Society of HematologyThe American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopeniaBlood201111716 4190 420721325604
   PubMed Web of Science ®Google Scholar
• El AlfyMSMokhtarGMEl-LaboudyMAKhalifaASRandomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpuraActa Haematol20061151–2 46 5216424649
   PubMed Web of Science ®Google Scholar
• Hedlund-TreutigerIHenterJIElinderGRandomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpuraJ Pediatr Hematol Oncol2003252 139 14412571466
   PubMed Web of Science ®Google Scholar
• MianoMRamenghiURussoGMycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncologyBr J Haematol20161753 490 49527447678
   PubMed Web of Science ®Google Scholar
• PatelAPPatilASDapsone for immune thrombocytopenic purpura in children and adultsPlatelets2015262 164 16724512442
   PubMed Web of Science ®Google Scholar
• BoruchovDMGururanganSDriscollMCBusselJBMultiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)Blood200711010 3526 353117698634
   PubMed Web of Science ®Google Scholar
• LiangYZhangLGaoJHuDAiYRituximab for children with immune thrombocytopenia: a systematic reviewPLoS One201275 e3669822666325
   PubMed Web of Science ®Google Scholar
• CooperNBusselJBThe long-term impact of rituximab for childhood immune thrombocytopeniaCurr Rheumatol Rep2010122 94 10020425017
   PubMedGoogle Scholar
• AhmedRDevasiaAJViswabandyaALong-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children: splenectomy in ITPAnn Hematol2016959 1429 143427370992
   PubMed Web of Science ®Google Scholar
• NugentDMcMillanRNicholJLSlichterSJPathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet productionBr J Haematol20091466 585 59619466980
   PubMed Web of Science ®Google Scholar
• NishimotoTOkazakiYNumajiriMKuwanaMMouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptorsInt J Hematol Epub20161227
   Web of Science ®Google Scholar
• YazdanbakhshKImbalanced immune homeostasis in immune thrombocytopeniaSemin Hematol201653Suppl 1 S16 S1927312156
   PubMed Web of Science ®Google Scholar
• KaushanskyKMolecular mechanisms of thrombopoietin signalingJ Thromb Haemost20097Suppl 1 235 238
   PubMed Web of Science ®Google Scholar
• LokSKaushanskyKHollyRDCloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivoNature19943696481 565 5688202158
   PubMed Web of Science ®Google Scholar
• KuterDJBegleyCGRecombinant human thrombopoietin: basic biology and evaluation of clinical studiesBlood200210010 3457 346912411315
   PubMed Web of Science ®Google Scholar
• LiJYangCXiaYThrombocytopenia caused by the development of antibodies to thrombopoietinBlood20019812 3241 324811719360
   PubMed Web of Science ®Google Scholar
• MolineuxGNewlandADevelopment of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedsideBr J Haematol20101501 9 2020298251
   PubMed Web of Science ®Google Scholar
• YangBBDoshiSArkamKFranklinJChowATDevelopment of romiplostim for treatment of primary immune thrombocytopenia from a pharmacokinetic and pharmacodynamic perspectiveClin Pharmacokinet2016559 1045 105827056734
   PubMed Web of Science ®Google Scholar
• CurraoMBalduiniCLBalduiniAHigh doses of romiplostim induce proliferation and reduce proplatelet formation by human megakaryocytesPLoS One201381 e5472323359807
   PubMed Web of Science ®Google Scholar
• KuterDJBusselJBLyonsRMEfficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialLancet20083719610 395 40318242413
   PubMed Web of Science ®Google Scholar
• KuterDJBusselJBNewlandALong-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacyBr J Haematol20131613 411 42323432528
   PubMed Web of Science ®Google Scholar
• RodeghieroFStasiRGiagounidisALong-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trialsEur J Haematol2013915 423 43623927437
   PubMedGoogle Scholar
• CinesDBGernsheimerTWasserJIntegrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostimInt J Hematol20151023 259 27026201709
   PubMed Web of Science ®Google Scholar
• Escudero VilaplanaVAragonésJHFernández-LlamazaresCMBielerCBRodríguezSMSáezMSUse of romiplostim for primary immune thrombocytopenia in childrenPediatr Hematol Oncol2012292 197 20522376020
   PubMed Web of Science ®Google Scholar
• Marquínez-AlonsoIEscudero-VilaplanaVPerníaSBeléndez BielerCFernández-LlamazaresCMSanjurjo-SáezMThe treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospitalJ Clin Pharm Ther2014394 376 38224702274
   PubMed Web of Science ®Google Scholar
• MokhtarGMTantawyAAEl SherifNHRomiplostim therapy in children with unresponsive chronic immune thrombocytopeniaPlatelets2012234 264 27322471399
   PubMed Web of Science ®Google Scholar
• SeidelMGUrbanCSipurzynskiJBeham-SchmidCLacknerHBeneschMHigh response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopeniaBr J Haematol20141653 419 42124484542
   PubMed Web of Science ®Google Scholar
• PasquetMAladjidiNGuitonCCentre de Référence National des Cytopénies Auto-immunes de l’Enfant (CEREVANCE)Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experienceBr J Haematol20141642 266 27124152194
   PubMed Web of Science ®Google Scholar
• RamaswamyKHsiehLLevenEThompsonMVNugentDBusselJBThrombopoietic agents for the treatment of persistent and chronic immune thrombocytopenia in childrenJ Pediatr20141653 600 605.e424857517
   PubMed Web of Science ®Google Scholar
• ThieleJKvasnickaHMFacchettiFFrancoVvan der WaltJOraziAEuropean consensus on grading bone marrow fibrosis and assessment of cellularityHaematologica2005908 1128 113216079113
   PubMed Web of Science ®Google Scholar
• NeunertCDespotovicJHaleyKPediatric ITP Consortium of North America (ICON)Thrombopoietin receptor agonist use in children: data from the pediatric ITP consortium of North America ICON2 StudyPediatr Blood Cancer2016638 1407 141327135461
   PubMed Web of Science ®Google Scholar
• ElalfyMSAbdelmaksoudAAEltonbaryKYRomiplostim in children with chronic refractory ITP: randomized placebo controlled studyAnn Hematol20119011 1341 134421318572
   PubMed Web of Science ®Google Scholar
• BusselJBBuchananGRNugentDJA randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopeniaBlood20111181 28 3621502541
   PubMed Web of Science ®Google Scholar
• BusselJBHsiehLBuchananGRLong-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)Pediatr Blood Cancer2015622 208 21325345874
   PubMed Web of Science ®Google Scholar
• TarantinoMDBusselJBBlanchetteVSRomiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled studyLancet201638810039 45 5427103127
   PubMed Web of Science ®Google Scholar
• KlaassenRJBlanchetteVSBarnardDValidity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids’ ITP ToolsJ Pediatr20071505 510 515 515.e117452226
   PubMed Web of Science ®Google Scholar
• KlaassenRJBlanchetteVBurkeTAQuality of life in childhood immune thrombocytopenia: international validation of the kids’ ITP toolsPediatr Blood Cancer2013601 95 10022848040
   PubMed Web of Science ®Google Scholar
• KlaassenRJMathiasSDBuchananGPilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP)Pediatr Blood Cancer2012583 395 39821910213
   PubMed Web of Science ®Google Scholar
• MathiasSDLiXEisenMCarpenterNCrosbyRDBlanchetteVSA phase 3, randomized, double-blind, placebo-controlled study to determine the effect of romiplostim on health-related quality of life in children with primary immune thrombocytopenia and associated burden in their parentsPediatr Blood Cancer2016637 1232 123727037553
   PubMed Web of Science ®Google Scholar